Cargando…

P1377: TRANSCRIPTOME-WIDE ANALYSIS OF T CELLS DURING EX VIVO EXPANSION AS PER CURRENT CAR T CELL MANUFACTURING PROTOCOL REVEALS SPECIFIC CHANGES IN T CELL SIGNALING AND HOMING

Detalles Bibliográficos
Autores principales:	Sudarsanam, Harish, Radtke, Maximilian, Buhmann, Raymund, Vučinić, Vladan, Abou-Jamra, Rami, Henschler, Reinhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430622/ http://dx.doi.org/10.1097/01.HS9.0000972396.17359.2c

Ejemplares similares

Influence of Culture Conditions on Ex Vivo Expansion of T Lymphocytes and Their Function for Therapy: Current Insights and Open Questions
por: Sudarsanam, Harish, et al.
Publicado: (2022)

Kindlin-2 Modulates the Survival, Differentiation, and Migration of Induced Pluripotent Cell-Derived Mesenchymal Stromal Cells
por: Moslem, Mohsen, et al.
Publicado: (2017)

COLLABORATION AGREEMENT No, K 1377
por: The Henryk Niewodniczanski Institute of Nuclear Physics of Polish Academy of Sciences, HNINP
Publicado: (2007)

Production and Application of CAR T Cells: Current and Future Role of Europe
por: Vucinic, Vladan, et al.
Publicado: (2021)

Guillaume de Machault, 130-?-1377
por: Machabey, Armand, 1886-
Publicado: (1955)

1377. Perinatal Transmission Dynamics of Antimicrobial Resistance
por: Styczynski, Ashley, et al.
Publicado: (2020)

Changes in the microRNA expression profile during blood storage
por: Haberberger, Anna, et al.
Publicado: (2018)

Association of Fas -1377 G/A Polymorphism with Susceptibility to Cancer
por: Geng, Peiliang, et al.
Publicado: (2014)

Correction to Lancet Respir Med 2021; 9: 1377–86
Publicado: (2021)

Global Manufacturing of CAR T Cell Therapy
por: Levine, Bruce L., et al.
Publicado: (2016)

Teclistamab impairs detection of BCMA CAR-T cells
por: Glatte, Bettina, et al.
Publicado: (2023)

Impact of Manufacturing Procedures on CAR T Cell Functionality
por: Watanabe, Norihiro, et al.
Publicado: (2022)

Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications
por: Blache, Ulrich, et al.
Publicado: (2021)

P1377: THE IMPACT OF THE TRAVELED DISTANCE TO THE TRANSPLANT CENTER ON THE CLINICAL OUTCOME OF ALLOGENIC BONE MARROW TRANSPLANT PATIENTS
por: El Cheikh, J., et al.
Publicado: (2022)

Rapid manufacturing of non-activated potent CAR T cells
por: Ghassemi, Saba, et al.
Publicado: (2022)

Potential solutions for manufacture of CAR T cells in cancer immunotherapy
por: Blache, Ulrich, et al.
Publicado: (2022)

Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera
por: Kannenberg, Judith, et al.
Publicado: (2021)

Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells
por: Leibacher, Johannes, et al.
Publicado: (2016)

Clinical manufacturing of CAR T cells: foundation of a promising therapy
por: Wang, Xiuyan, et al.
Publicado: (2016)

Optimization of metabolism to improve efficacy during CAR-T cell manufacturing
por: Zhang, Meng, et al.
Publicado: (2021)

Steering CAR T cell epigenetic programs by tweaking manufacturing protocol
por: Dukes, Meghan W., et al.
Publicado: (2023)

1377. Rabies and Tetanus Post-Exposure Prophylaxis Initiation in the US and Overseas: Consistent with ACIP Recommendations?
por: Chirumamilla, Siri L, et al.
Publicado: (2023)

A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma
por: Ladd, Alden, et al.
Publicado: (2015)

Optimizing CAR-T Cell Manufacturing Processes during Pivotal Clinical Trials
por: Tyagarajan, Seshu, et al.
Publicado: (2019)

Large-scale manufacturing and characterization of CMV-CD19CAR T cells
por: Wang, Xiuli, et al.
Publicado: (2022)

Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells
por: Agarwalla, Pritha, et al.
Publicado: (2022)

Characterization of CAR T Cells Manufactured Using Genetically Engineered Artificial Antigen Presenting Cells
por: Sayadmanesh, Ali, et al.
Publicado: (2023)

Accumulated Clinical Experiences from Successful Treatment of 1377 Severe and Critically Ill COVID-19 Cases
por: Gao, Yong, et al.
Publicado: (2020)

Exome first approach to reduce diagnostic costs and time – retrospective analysis of 111 individuals with rare neurodevelopmental disorders
por: Klau, Julia, et al.
Publicado: (2021)

Approach to Cohort-Wide Re-Analysis of Exome Data in 1000 Individuals with Neurodevelopmental Disorders
por: Halfmeyer, Insa, et al.
Publicado: (2022)

Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience
por: Dreger, Peter, et al.
Publicado: (2022)

1377. Impact of Pre-Transplant Infectious Diseases Wellness Visit on Vaccine Uptake in Solid Organ Transplant Candidates
por: Parraga, Tommy J, et al.
Publicado: (2021)

The potential role of short chain fatty acids improving ex vivo T and CAR-T cell fitness and expansion for cancer immunotherapies
por: González-Brito, Adrián, et al.
Publicado: (2023)

Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing
por: Balke-Want, Hyatt, et al.
Publicado: (2023)

Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy
por: Georgi, Thomas Walter, et al.
Publicado: (2023)

Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34(pos) Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction
por: Moslem, Mohsen, et al.
Publicado: (2015)

Aberrant epigenetic regulators control expansion of human CD34+ hematopoietic stem/progenitor cells
por: Faridi, Farnaz, et al.
Publicado: (2013)

Get Off on the Right Foot: How to Plan an Efficient Leukocytapheresis to Collect T Cells for CAR T-Cell Manufacturing
por: Piñeyroa, Juan A., et al.
Publicado: (2022)

Development and Validation of a Good Manufacturing Process for IL-4-Driven Expansion of Chimeric Cytokine Receptor-Expressing CAR T-Cells
por: van Schalkwyk, May C. I., et al.
Publicado: (2021)

The expansion of targetable biomarkers for CAR T cell therapy
por: Townsend, Michelle H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6qrjneqkbgtvj7r4prjb091jeb